MIRA PHARMACEUTICALS INC (MIRA) Forecast, Price Target & Analyst Ratings

NASDAQ:MIRA • US60458C1045

Current stock price

1.05 USD
-0.08 (-7.08%)
At close:
1.0316 USD
-0.02 (-1.75%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for MIRA PHARMACEUTICALS INC (MIRA).

Forecast Snapshot

Consensus Price Target

Price Target
$3.06
+ 191.43% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 12, 2026
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
82.86%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$3.06
Upside
+ 191.43%
From current price of $1.05 to mean target of $3.06, Based on 7 analyst forecasts
Low
$3.03
Median
$3.06
High
$3.15

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

7 Wall Street analysts provided a forecast for the next 12 months for MIRA. The average price target is 3.06 USD. This implies a price increase of 191.43% is expected in the next year compared to the current price of 1.05.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

MIRA Current Analyst RatingMIRA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

MIRA Historical Analyst RatingsMIRA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
82.86%
MIRA was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about MIRA.
In the previous month the buy percentage consensus was at a similar level.
MIRA was analyzed by 7 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2024-09-30Rodman & RenshawInitiate Buy
2024-08-05Ascendiant CapitalInitiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 12, 2026

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2020 2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
MIRA revenue by date.MIRA revenue by date.
N/A
EBITDA
YoY % growth
MIRA ebitda by date.MIRA ebitda by date.
N/AN/AN/AN/AN/AN/A
-9.81%		N/A
6,240.78%
EBIT
YoY % growth
MIRA ebit by date.MIRA ebit by date.
-67.6K-2.152M
-3,083.73%		-7.048M
-227.47%		-8.526M
-20.97%		-8.018M
5.96%		-10.493M
-30.86%		N/A
5,369.37%
Operating Margin
MIRA operating margin by date.MIRA operating margin by date.
N/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
MIRA eps by date.MIRA eps by date.
N/AN/AN/AN/A-0.52
25.03%		N/A
-129.50%		N/A
84.62%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

MIRA Yearly EPS VS EstimatesMIRA Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 -0.2 -0.4 -0.6 -0.8 -1

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
N/A
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

MIRA PHARMACEUTICALS INC / MIRA Forecast FAQ

What is the average price target for MIRA PHARMACEUTICALS INC (MIRA) stock?

7 analysts have analysed MIRA and the average price target is 3.06 USD. This implies a price increase of 191.43% is expected in the next year compared to the current price of 1.05.

When does MIRA PHARMACEUTICALS INC (MIRA) report earnings?

MIRA PHARMACEUTICALS INC (MIRA) will report earnings on 2026-05-12.

Can you provide the analyst count for MIRA PHARMACEUTICALS INC stock?

The number of analysts covering MIRA PHARMACEUTICALS INC (MIRA) is 7.